Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.830
+0.250 (15.82%)
At close: Jun 22, 2026, 4:00 PM EDT
1.870
+0.040 (2.19%)
After-hours: Jun 22, 2026, 7:34 PM EDT

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $127.44K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $333.14K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

Revenue (ttm)
$333.14K
Revenue Growth
n/a
P/S Ratio
662.11
Revenue / Employee
$19,597
Employees
17
Market Cap
221.18M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 20198.15M5.06M163.84%
Sep 30, 20183.09M-723.96K-18.99%
Sep 30, 20173.81M831.94K27.92%
Sep 30, 20162.98M-2.24M-42.91%
Sep 30, 20155.22M-3.83M-42.33%
Sep 30, 20149.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Compugen72.66M
LENZ Therapeutics20.99M
Alector18.42M
Tonix Pharmaceuticals Holding17.56M
ProQR Therapeutics15.73M
MediWound14.48M
Equillium4.39M
Korro Bio3.84M
Revenue Rankings

OTLK News

More News